TrialThe European respiratory journal2021
Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.
Toby M Maher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled itcites it